Gross alpha/beta and radionuclide activity concentrations in soil, plant and some fruits around the Tehran Research Reactor.

Human activities usually have some contamination as effluents from chemical industries and radionuclides from nuclear reactors. For assessing the probable radioactive contamination in vicinity of Tehran Research Reactor, The gross alpha and beta radioactivity concentrations in soil, pine and cedar leaves and some selected fruits (fig, apple, berry and pomegranate) were investigated using an alpha/beta spectrometer during 2021-2022. Also, the concentrations of artificial and natural radionuclides in samples were investigated by the method of gamma spectroscopy. The gross alpha activity concentrations in soil, pine and cedar leaves and some selected fruits samples are from 0.05 to 0.35 Bq/gr and 0.07-0.31 Bq/gr and 0.04-0.18 Bq/gr, respectively. The gross beta activity concentrations in soil, pine and cedar leaves and some selected fruit samples are from 0.73 to 4.25 Bq/gr and 0.21-3.97 Bq/gr and 1.01-2.71 Bq/gr, respectively. Average activities concentration of natural radionuclide 232Th, 238U and 40K in soil, pine and cedar leaves and some selected fruits are 31.89-16.23-582.73 Bq/kg and 1.84-0.99-84.60 Bq/kg and 1.98-1.09-72.08 Bq/kg respectively. From artificial radionuclides, just 137Cs is recognized in soil sample and the range of 137Cs concentration in surface soils was observed to vary in the range 0.85-2.21 (Bq/kg). The result showed that the Tehran Research Reactor activities not have increased the environmental radioactivity and radiation level in the area.

The transulnar approach in the patients with ipsilateral radial artery occlusion.

BACKGROUND: Transulnar approach (TUA) has been classified as an appropriate surrogate for the transradial approach (TRA), but the safety of TUA in the presence of ipsilateral radial artery occlusion (RAO) is not well studied. In this article, we aimed to assess the feasibility and occurrence of complications of this approach in Iranian individuals with ipsilateral RAO. METHODS: In this prospective double-center study, a total number of 70 participants from July 2017 to November 2018 with coexisting ipsilateral RAO due to prior RA angiography, severe arterial spasm, prominent vascular anomalies, or arterial harvesting for hemodialysis or graft procedures were enrolled and underwent TUA. Incidence of probable complications including pain, hematoma, arteriovenous fistula (AVF), pseudoaneurysm formation, any adverse events requiring immediate vascular surgery, life-threatening hand ischemia, infection, ulnar nerve palsy, major adverse cardiac events (MACE) including death, myocardial infarction (MI), or stroke plus ulnar artery (UA) obstruction and narrowing was evaluated both before discharge time and one month afterward. RESULTS: The mean age of the study population was 68.2 ± 12.8 years [men number: 41 (58.5%)]. Our success rate was 98.6% and 37.1% of subjects underwent further coronary intervention. No aforementioned adverse outcomes were reported in any individual except for pain (11.4%) and minor hematoma (grade I) (5.7%) as well as MACE (1.4%). Follow-up assessment revealed asymptomatic UA occlusion (UAO) and severe narrowing in 2.8% and 1.4% of participants, respectively. CONCLUSION: Our outcomes suggested that due to high safety and low complication rates, TUA could be tried safely in patients with concurrent ipsilateral RAO. Other appropriate cohort studies are required for assessing the incidence of TUA complications.

Comparing efficacy of receiving different dosages of eptifibatide in bleeding after percutaneous coronary intervention in patients with myocardial infarction.

BACKGROUND: Acute coronary syndrome (ACS) is a common condition that needs appropriate treatment like percutaneous coronary intervention (PCI). Glycoprotein IIb/IIIa inhibitors (GPI) like eptifibatide prevent procedural ischemic complications after PCI. Eptifibatide has increased the risk of bleeding complications, although it is effective in reducing mortality and morbidity. Eptifibatide is routinely used in bolus and infusion forms and the aim of this study is to evaluate the efficacy of bolus-only dose and bolus + infusion strategy for administrating eptifibatide in bleeding complications and consequences after PCI. METHODS: This randomized clinical trial was conducted on subjects who experienced PCI after incidence of myocardial infarction (MI). Patients were randomly divided into two groups who received bolus-only dose (n = 51) or bolus + infusion form of eptifibatide (n = 50). Then, PCI blood pressure, mean time duration of hemostasis after arterial sheath removal, laboratory data, need for blood transfusion, and presence of bleeding complications were evaluated. After 6 months, patients were followed for needs for additional coronary interventions. RESULTS: The mean age of participants was 61.68 ± 1.50 years. The prevalence of men was 70.29%. There was no significant difference in mean of systolic blood pressure (SBP) and diastolic blood pressure (DBP) during hospitalization (P > 0.050). The mean time duration of hemostasis was 8.13 ± 0.45 minutes in the bolus-only group and 16.46 ± 0.71 minutes in the bolus + infusion group (P < 0.001). There was no significant difference in the hemoglobin (Hb) level, platelet count, white blood cell (WBC), blood urea nitrogen (BUN), and creatinine level (P > 0.050). CONCLUSION: The results of this study suggested that bolus-only dose of eptifibatide before PCI could be able to decrease significantly bleeding complication and other clinical and cardiovascular outcomes.

Silymarin-albumin nanoplex: Preparation and its potential application as an antioxidant in nervous system in vitro and in vivo.

In this study, we formulated silymarin-HSA nanoplex and assayed its ability to reduce LPS-induced toxicity in vitro and in vivo. Silymarin molecules were encapsulated into HSA nanoplex and the loading efficiency and characterization of fabricated nanoplex were performed by using HPLC, TEM, SEM, DLS, FTIR analysis, and theoretical studies. Afterwards, their protective effect against LPS (20 µg/ml) -induced toxicity in SH-SY5Y cells was investigated by MTT, ROS, and apoptosis assays. For in vivo experiments, rats were pre-treated with either silymarin or silymarin -HSA nanoplex (200 mg/kg) orally for 3 days and at third day received LPS by IP at a dose of 0.5 mg/kg, 150 min before scarification followed by SOD and CAT activity assay. The formulation of silymarin-HSA nanoplex showed a spherical shape with an average diameter between 50 nm and 150 nm, hydrodynamic radius of 188.3 nm, zeta potential of -26.6 mV, and a drug loading of 97.3%. In LPS-treated cells, pretreatments with silymarin-HSA noncomplex recovered the cell viability and decreased the ROS level and corresponding apoptosis more significantly than free silymarin. In rats, it was also depicted that, silymarin-HSA noncomplex can increase the SOD and CAT activity in brain tissue at LPS-triggered oxidative stress model more significantly than the free counterpart. Therefore, nanoformulation of silymarin improved its capability to reduce LPS-induced oxidative stress by restoring cell viability and elevation of SOD and CAT activity in vitro and in vivo, respectively. In conclusion, formulation of silymarin may hold a great promise in the development of antioxidant agents.

ASSESSMENT OF TERRESTRIAL RADIATION BY DIRECT MEASUREMENT OF AMBIENT DOSE EQUIVALENT RATE OF BACKGROUND RADIATION.

Estimation of terrestrial external radiation is essential for assessment of public exposure to natural radiation. During national survey of natural radionuclide in soil in Iran, 979 soil samples were collected from different locations, in the same time ambient dose equivalent rate was measured by a scintillator detector. In this work, terrestrial radiation was estimated by direct measurement of ambient dose equivalent rate of background radiation. The response of dose measuring instrument to cosmic radiation at ground level was measured and other components were discussed and estimated. For verification, terrestrial radiation derived from this method was compared with those calculated from activity concentration of natural radionuclides in soil. The averages of ambient dose equivalent rate derived from activity concentration of by natural radionuclide in soil and from direct measurement are 55.07 and 62.57 nSv/h, respectively. The source of statistical and systematic uncertainties are introduced and discussed.